158 related articles for article (PubMed ID: 24648315)
1. Comparing HIV viral load assays and frequency of low level virological rebound in clinical practice.
Briggs R; Templeton K; Fernando I
Int J STD AIDS; 2014 Dec; 25(14):1029-34. PubMed ID: 24648315
[TBL] [Abstract][Full Text] [Related]
2. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management.
Garrett NJ; Apea V; Nori A; Ushiro-Lumb I; Oliver AR; Baily G; Clark DA
J Clin Virol; 2012 Apr; 53(4):354-5. PubMed ID: 22261125
[TBL] [Abstract][Full Text] [Related]
6. Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.
Taylor N; Grabmeier-Pfistershammer K; Egle A; Greil R; Rieger A; Ledergerber B; Oberkofler H
PLoS One; 2013; 8(8):e74024. PubMed ID: 24023696
[TBL] [Abstract][Full Text] [Related]
7. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load.
Mor O; Gozlan Y; Wax M; Mileguir F; Rakovsky A; Noy B; Mendelson E; Levy I
J Clin Microbiol; 2015 Nov; 53(11):3458-65. PubMed ID: 26292298
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.
Bronze M; Aitken SC; Wallis CL; Steegen K; Stuyver LJ; de Wit TF; Stevens W
J Virol Methods; 2013 Dec; 194(1-2):300-7. PubMed ID: 23994150
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
[TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: a comparative study.
Paba P; Fabeni L; Ciccozzi M; Perno CF; Ciotti M
J Virol Methods; 2011 May; 173(2):399-402. PubMed ID: 21419171
[TBL] [Abstract][Full Text] [Related]
12. Comparative performance of the new Aptima HIV-1 Quant Dx assay with three commercial PCR-based HIV-1 RNA quantitation assays.
Hopkins M; Hau S; Tiernan C; Papadimitropoulos A; Chawla A; Beloukas A; Geretti AM
J Clin Virol; 2015 Aug; 69():56-62. PubMed ID: 26209380
[TBL] [Abstract][Full Text] [Related]
13. Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains.
Avettand-Fénoël V; Mélard A; Gueudin M; Maillard A; Dina J; Gousset M; Chaix ML; Lerolle N; Viard JP; Meyer L; Plantier JC; Rouzioux C;
J Clin Virol; 2019 Jan; 110():36-41. PubMed ID: 30530097
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification.
Tung YC; Ke LY; Lu PL; Lin KH; Lee SC; Lin YY; Chou LC; Tsai WC
Kaohsiung J Med Sci; 2015 Apr; 31(4):188-93. PubMed ID: 25835274
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes.
Cloherty G; Swanson P; Lucic D; Dieckhaus K; Anthony P; Cataline P; Herman C; Hackett J; Skolnik PR; Chirch L
J Virol Methods; 2014 Aug; 204():91-2. PubMed ID: 24747107
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 variability and viral load technique could lead to false positive HIV-1 detection and to erroneous viral quantification in infected specimens.
Alvarez P; Martín L; Prieto L; Obiang J; Vargas A; Avedillo P; Rojo P; Fernández McPhee C; Benito A; Ramos JT; Holguín Á
J Infect; 2015 Sep; 71(3):368-76. PubMed ID: 26033694
[TBL] [Abstract][Full Text] [Related]
17. Low-level viremia associated with the use of TaqMan assay.
Szabo S; Moffett LE; Cantwell-McNelis K; James CW; Joseph A
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):203-5. PubMed ID: 20530465
[TBL] [Abstract][Full Text] [Related]
18. Viral load assay sensitivity and low level viremia in HAART treated HIV patients.
Verhofstede C; Van Wanzeele F; Reynaerts J; Mangelschots M; Plum J; Fransen K
J Clin Virol; 2010 Apr; 47(4):335-9. PubMed ID: 20138803
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants.
Mourez T; Delaugerre C; Vray M; Lemée V; Simon F; Plantier JC
J Clin Virol; 2015 Oct; 71():76-81. PubMed ID: 26318912
[TBL] [Abstract][Full Text] [Related]
20. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays.
Sire JM; Vray M; Merzouk M; Plantier JC; Pavie J; Maylin S; Timsit J; Lascoux-Combe C; Molina JM; Simon F; Delaugerre C
J Acquir Immune Defic Syndr; 2011 Mar; 56(3):239-43. PubMed ID: 21164353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
